ClinicalTrials.gg
Not yet recruitingNCT07889037DEBRIEF-TUpdated Oct 22, 2026

Structured Debriefing and Institutional Trust After a Mass-Casualty Simulation

An interventional study of Standard debriefing (PEARLS Method) and Standard debriefing (PEARLS Method) + support module in Mass-casualty Incident Preparedness, sponsored by Assistance Publique - Hôpitaux de Paris. Not yet recruiting at 1 site in France. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Health services research

Updated Oct 22, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This single-center, randomized, parallel-group trial evaluates whether adding a structured psychological and organizational support module to the standard technical debriefing via the PEARLS method after a full-scale hospital mass-casualty incident simulation increases healthcare professionals' confidence in their institution's ability to respond to a mass-casualty incident. Adult hospital professionals with an operational role in the exercise will complete a baseline questionnaire immediately after the exercise and before allocation. Participants will then be randomized 1:1 to standard debriefing control module or to standard debriefing plus a structured psychological and organizational support module. The primary outcome is the post-debriefing institutional confidence score, calculated as the mean of three 7-point Likert items and analyzed with adjustment for the pre-debriefing score.

Read the detailed description

All participants will take part in the same full-scale hospital exercise, which is organized independently of the research. Immediately after the exercise and before allocation (T1), participants will complete the three institutional-confidence items. Individual randomization will then be performed 1:1 using a computer-generated sequence with concealed allocation. Both groups will receive the same standardized technical/factual debriefing. The control group will additionally receive a duration-matched factual and organizational module without a specific psychological-support component. The intervention group will receive a structured module including non-pathologizing recognition and normalization of stress reactions, staff safety and support, transparent institutional communication, protection of personnel, available support resources, and explanation of how difficulties identified during the exercise will inform improvement of the exercise plan. The primary endpoint is the institutional confidence score immediately after debriefing (T2), defined as the unweighted mean of three 7-point Likert items covering preparedness, institutional honesty and acting in professionals' interests. The primary analysis will use a linear model/ANCOVA with T2 score as the dependent variable, randomized group as the main factor and T1 score as a covariate. Secondary outcomes include psychological safety, perceived organizational support, willingness to participate in a future real response, and debriefing acceptability/usefulness/tolerability. Debriefing quality and fidelity will be documented using the Debriefing Assessment for Simulation in Healthcare (DASH). The target is to randomize all participants to obtain approximately 50 analyzable responses. No patient data, medication, biological sample or medical procedure is involved. The DASH will be used as a process measure to assess the quality and fidelity of debriefing delivery. DASH scores will be reported to document whether the overall quality of debriefing was comparable between the standard debriefing group and the standard debriefing plus structured psychological and organizational support module group.

02

Conditions studied

  • Mass-casualty Incident Preparedness

Keywords

  • Mass-casualty simulation
  • debriefing
  • institutional trust
03

In context

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,576 studies on the registry; 1,028 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult hospital professional with an operational role during the exercise
  • study information received
  • voluntary agreement to participate

Exclusion criteria

Exclusion Criteria:

  • actors or standardized patients playing victims
  • evaluators, organizers, or facilitators without an operational role in the scenario
  • refusal to participate in the study
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Standard debriefing (PEARLS Method)

    Standardized debriefing using the PEARLS method without the specific psychological-support component.

    Other: Standard debriefing (PEARLS Method)

  • Experimental
    Standard debriefing (PEARLS Method) + support module

    Standardized debriefing using the PEARLS method with the specific psychological-support component developed by psychologist

    Other: Standard debriefing (PEARLS Method) + support module

Interventions

  • OtherStandard debriefing (PEARLS Method)

    Standardized debriefing using the PEARLS method without a specific psychological-support component.

  • OtherStandard debriefing (PEARLS Method) + support module

    Standardized debriefing using the PEARLS method with a specific psychological-support component.

06

What researchers measure

Primary outcomes

  1. Institutional confidence score

    Unweighted mean of three 7-point Likert items (1=strongly disagree to 7=strongly agree) assessing perceived hospital preparedness for an AMAVI, institutional honesty toward professionals, and the belief that the hospital would act in professionals' interests.

    Time frame: Immediately after debriefing (T2)

Secondary outcomes

  1. Psychological safety score

    Psychological safety assessed using the 6-item SCORE Psychological Safety Scale.

    Time frame: immediately after debriefing (T2)

  2. Willingness to participate in a future mass casualty response

    Self-reported willingness to participate in the response to a future real mass-casualty incident, measured on a 1-to-7 Likert scale

    Time frame: immediately after debriefing (T2)

  3. State-Trait Anxiety Inventory

    A validated 20-item self-report questionnaire assessing current state anxiety. Each item is rated on a 4-point Likert scale (1 to 4), with positively worded items reverse-scored as appropriate. Item scores are summed to obtain a total score ranging from 20 to 80, with higher scores indicating greater state anxiety

    Time frame: immediately after debriefing (T2)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Oct 2026, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 16, 2026
First posted
Oct 22, 2026
StartEst.
Oct 2026
Primary completionEst.
Oct 31, 2026
CompletionEst.
Oct 31, 2026
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07889037
Responsible party
Sponsor
First posted
Oct 22, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 31, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Oct 22, 2026

Study contacts

Myriam Lamamri, MD
Contact
dorssaf.lamamri@aphp.fr
33140888773
Myriam Lamamri, MD
principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion